根据ESI于2022年7月发布的数据，我校高被引论文（Highly Cited Papers）230篇，热点论文（Hot Papers）7篇，见附件：2022年7月南方医科大学高被引论文及热点论文简表。详情如下。
从学科角度看，在230篇高被引论文中，临床医学最多（107篇），占比46.52%，分子生物学与遗传学24篇 (10.43%)第二、生物学与生物化学19篇（8.26%）紧跟其后。
|
序号 |
高被引论文 Research Field |
202205 |
202207 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
1 |
CLINICAL MEDICINE |
108 |
49.09% |
107 |
46.52% |
|
2 |
MOLECULAR BIOLOGY & GENETICS |
21 |
9.55% |
24 |
10.43% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
21 |
9.55% |
19 |
8.26% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
13 |
5.91% |
18 |
7.83% |
|
5 |
MATERIALS SCIENCE |
10 |
4.55% |
13 |
5.65% |
|
6 |
NEUROSCIENCE & BEHAVIOR |
7 |
3.18% |
7 |
3.04% |
|
7 |
ENGINEERING |
6 |
2.73% |
5 |
2.17% |
|
8 |
MICROBIOLOGY |
6 |
2.73% |
7 |
3.04% |
|
9 |
CHEMISTRY |
5 |
2.27% |
5 |
2.17% |
|
10 |
PHYSICS |
2 |
0.91% |
2 |
0.87% |
|
11 |
PSYCHIATRY/PSYCHOLOGY |
8 |
3.64% |
8 |
3.48% |
|
12 |
IMMUNOLOGY |
2 |
0.91% |
3 |
1.30% |
|
13 |
SOCIAL SCIENCES, GENERAL |
4 |
1.82% |
4 |
1.74% |
|
14 |
COMPUTER SCIENCE |
3 |
1.36% |
3 |
1.30% |
|
15 |
GEOSCIENCES |
1 |
0.45% |
1 |
0.43% |
|
16 |
AGRICULTURAL SCIENCES |
0 |
0.00% |
1 |
0.43% |
|
17 |
MULTIDISCIPLINARY |
1 |
0.45% |
1 |
0.43% |
|
18 |
ENVIRONMENT/ECOLOGY |
2 |
0.91% |
2 |
0.87% |
|
19 |
合计 |
220 |
100.00% |
230 |
100.00% |
|
序号 |
2022年7月我校7篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
COMORBIDITY AND ITS IMPACT ON 1590 PATIENTS WITH COVID-19 IN CHINA: A NATIONWIDE ANALYSIS |
EUROPEAN RESPIRATORY JOURNAL 55 (5): - MAY 1 2020 |
10.1183/13993003.00547-2020 |
CLINICAL MEDICINE |
2157 |
|
2 |
DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
NEW ENGLAND JOURNAL OF MEDICINE 383 (15): 1436-1446 OCT 8 2020 |
10.1056/NEJMoa2024816 |
CLINICAL MEDICINE |
740 |
|
3 |
DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE TO PREDICT THE OCCURRENCE OF CRITICAL ILLNESS IN HOSPITALIZED PATIENTS WITH COVID-19 |
JAMA INTERNAL MEDICINE 180 (8): 1081-1089 AUG 2020 |
10.1001/jamainternmed.2020.2033 |
CLINICAL MEDICINE |
515 |
|
4 |
STRUCTURAL AND FUNCTIONAL PROPERTIES OF SARS-COV-2 SPIKE PROTEIN: POTENTIAL ANTIVIRUS DRUG DEVELOPMENT FOR COVID-19 |
ACTA PHARMACOLOGICA SINICA 41 (9): 1141-1149 SEP 2020 |
10.1038/s41401-020-0485-4 |
PHARMACOLOGY & TOXICOLOGY |
485 |
|
5 |
GUIDELINES FOR THE USE AND INTERPRETATION OF ASSAYS FOR MONITORING AUTOPHAGY (4TH EDITION) |
AUTOPHAGY 17 (1): 1-382 2021 |
10.1080/15548627.2020.1797280 |
MOLECULAR BIOLOGY & GENETICS |
179 |
|
6 |
RAPID AND SENSITIVE DETECTION OF ANTI-SARS-COV-2 IGG, USING LANTHANIDE-DOPED NANOPARTICLES-BASED LATERAL FLOW IMMUNOASSAY |
ANALYTICAL CHEMISTRY 92 (10): 7226-7231 MAY 19 2020 |
10.1021/acs.analchem.0c00784 |
CHEMISTRY |
164 |
|
7 |
ADVANCES IN HYDROGEL-BASED VASCULARIZED TISSUES FOR TISSUE REPAIR AND DRUG SCREENING |
BIOACTIVE MATERIALS 9: 198-220 MAR 2022 |
10.1016/j.bioactmat.2021.07.005 |
MATERIALS SCIENCE |
5 |
